189 related articles for article (PubMed ID: 26299420)
1. Reflectance confocal microscopy for plaque psoriasis therapeutic follow-up during an anti-TNF-α monoclonal antibody: an observational multicenter study.
Ardigò M; Agozzino M; Longo C; Lallas A; Di Lernia V; Fabiano A; Conti A; Sperduti I; Argenziano G; Berardesca E; Pellacani G
J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2363-8. PubMed ID: 26299420
[TBL] [Abstract][Full Text] [Related]
2. Reflectance confocal microscopy for plaque psoriasis therapeutic follow-up during an anti-interleukin-17A monoclonal antibody: an observational study.
Jiang Q; Qu Z; Wang B; Jiang R; Zhou Y; Wan L; Chen L; Hu F
Sci Rep; 2024 Jul; 14(1):15121. PubMed ID: 38956402
[TBL] [Abstract][Full Text] [Related]
3. Psoriasis plaque test with confocal microscopy: evaluation of different microscopic response pathways in NSAID and steroid treated lesions.
Ardigò M; Agozzino M; Longo C; Conti A; Di Lernia V; Berardesca E; Pellacani G
Skin Res Technol; 2013 Nov; 19(4):417-23. PubMed ID: 23521429
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the response to treatment of psoriasis vulgaris with reflectance confocal microscopy.
Başaran YK; Gürel MS; Erdemir AT; Turan E; Yurt N; Bağci IS
Skin Res Technol; 2015 Feb; 21(1):18-24. PubMed ID: 24528203
[TBL] [Abstract][Full Text] [Related]
5. Concordance between in vivo reflectance confocal microscopy and histology in the evaluation of plaque psoriasis.
Ardigo M; Cota C; Berardesca E; González S
J Eur Acad Dermatol Venereol; 2009 Jun; 23(6):660-7. PubMed ID: 19243485
[TBL] [Abstract][Full Text] [Related]
6. Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics.
Papoutsaki M; Chimenti MS; Costanzo A; Talamonti M; Zangrilli A; Giunta A; Bianchi L; Chimenti S
J Am Acad Dermatol; 2007 Aug; 57(2):269-75. PubMed ID: 17574299
[TBL] [Abstract][Full Text] [Related]
7. Efficacy comparison of ustekinumab between anti-tumor necrosis factor-α drug-naïve and anti-tumor necrosis factor-α drug-resistant Japanese psoriasis cases.
Takahashi N; Noda S; Taniguchi T; Adachi M
Int J Dermatol; 2015 Oct; 54(10):1194-8. PubMed ID: 26016819
[TBL] [Abstract][Full Text] [Related]
8. Adalimumab for treatment of moderate to severe psoriasis and psoriatic arthritis.
Bongiorno MR; Pistone G; Doukaki S; Aricò M
Dermatol Ther; 2008 Oct; 21 Suppl 2():S15-20. PubMed ID: 18837728
[TBL] [Abstract][Full Text] [Related]
9. Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: results from a randomized, controlled Phase III study.
Revicki DA; Menter A; Feldman S; Kimel M; Harnam N; Willian MK
Health Qual Life Outcomes; 2008 Oct; 6():75. PubMed ID: 18831744
[TBL] [Abstract][Full Text] [Related]
10. Pathway Analysis of Skin from Psoriasis Patients after Adalimumab Treatment Reveals New Early Events in the Anti-Inflammatory Mechanism of Anti-TNF-α.
Langkilde A; Olsen LC; Sætrom P; Drabløs F; Besenbacher S; Raaby L; Johansen C; Iversen L
PLoS One; 2016; 11(12):e0167437. PubMed ID: 28005985
[TBL] [Abstract][Full Text] [Related]
11. Treatment of psoriasis with adalimumab.
Pitarch G; Sanchez-Carazo JL; Mahiques L; Perez-Ferriols MA; Fortea JM
Clin Exp Dermatol; 2007 Jan; 32(1):18-22. PubMed ID: 17305904
[TBL] [Abstract][Full Text] [Related]
12. Anti-TNF agents for the treatment of psoriasis.
Kircik LH; Del Rosso JQ
J Drugs Dermatol; 2009 Jun; 8(6):546-59. PubMed ID: 19537380
[TBL] [Abstract][Full Text] [Related]
13. Sustained efficacy and safety of adalimumab in psoriasis treatment: a retrospective study of 49 patients with and without a history of TNF-alpha antagonist treatment.
Van L; Modi SV; Yang DJ; Hsu S
Arch Dermatol; 2008 Jun; 144(6):804-6. PubMed ID: 18559778
[No Abstract] [Full Text] [Related]
14. Recalcitrant psoriatic uveitis and anti-tumor necrosis factor-α monoclonal antibodies: experience from a psoriasis referral center.
Fotiadou C; Lazaridou E; Kemanetzi C; Kyrmanidou E; Ioannides D
Int J Dermatol; 2015 Sep; 54(9):1105-8. PubMed ID: 25557117
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of adalimumab in patients with psoriasis previously treated with anti-tumour necrosis factor agents: subanalysis of BELIEVE.
Ortonne JP; Chimenti S; Reich K; Gniadecki R; Sprøgel P; Unnebrink K; Kupper H; Goldblum O; Thaçi D
J Eur Acad Dermatol Venereol; 2011 Sep; 25(9):1012-20. PubMed ID: 21214631
[TBL] [Abstract][Full Text] [Related]
16. Impact of adalimumab treatment on patient-reported outcomes: results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis.
Revicki DA; Willian MK; Menter A; Gordon KB; Kimball AB; Leonardi CL; Langley RG; Kimel M; Okun M
J Dermatolog Treat; 2007; 18(6):341-50. PubMed ID: 18058494
[TBL] [Abstract][Full Text] [Related]
17. Reflectance confocal microscopy: an effective tool for monitoring ultraviolet B phototherapy in psoriasis.
Wolberink EA; van Erp PE; de Boer-van Huizen RT; van de Kerkhof PC; Gerritsen MJ
Br J Dermatol; 2012 Aug; 167(2):396-403. PubMed ID: 22512282
[TBL] [Abstract][Full Text] [Related]
18. Anti-TNF-α therapy improves insulin sensitivity in non-diabetic patients with psoriasis: a 6-month prospective study.
Pina T; Armesto S; Lopez-Mejias R; Genre F; Ubilla B; Gonzalez-Lopez MA; Gonzalez-Vela MC; Corrales A; Blanco R; Garcia-Unzueta MT; Hernandez JL; Llorca J; Gonzalez-Gay MA
J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1325-30. PubMed ID: 25353352
[TBL] [Abstract][Full Text] [Related]
19. Relationship of leptin with adiposity and inflammation and resistin with disease severity in psoriatic patients undergoing anti-TNF-alpha therapy.
Pina T; Genre F; Lopez-Mejias R; Armesto S; Ubilla B; Mijares V; Dierssen-Sotos T; Gonzalez-Lopez MA; Gonzalez-Vela MC; Blanco R; Hernández JL; Llorca J; Gonzalez-Gay MA
J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1995-2001. PubMed ID: 25823684
[TBL] [Abstract][Full Text] [Related]
20. A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis.
Gordon KB; Duffin KC; Bissonnette R; Prinz JC; Wasfi Y; Li S; Shen YK; Szapary P; Randazzo B; Reich K
N Engl J Med; 2015 Jul; 373(2):136-44. PubMed ID: 26154787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
